Europe Israel

Europe Israel (M.M.S.) Ltd., commonly known as the Europe Israel Group, is an Israeli investment and holding company that has historically played a significant role in the life sciences and medical technology sectors. The company gained prominence as the controlling shareholder of Elbit Medical Imaging (now Elbit Imaging), which served as a major vehicle for healthcare innovation, overseeing pioneering subsidiaries such as Insightec and Gamida Cell. Through these holdings, Europe Israel spearheaded the development of transformative technologies, including MR-guided focused ultrasound for neurological disorders and advanced cell therapies for cancer and rare genetic diseases. Although the group underwent a major financial restructuring and debt settlement in 2013, the Europe Israel brand continues to operate as a private investment entity focused on technology, real estate, and innovation. Its legacy in the healthcare sector is defined by its early and influential backing of high-impact medical ventures that have achieved global commercial success.